Related Experiment Video
Updated: Oct 9, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival
A Haapasalo1, E Koponen, E Hoppe
1A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, 70211, Finland.
Abstract:
Truncated trkB.T1 (T1) neurotrophin receptor inhibits full-length trkB.TK+ (TK+) signaling. At least two possible mechanisms have been proposed for this action: T1 could trap the ligand or function as a dominant negative receptor. To differentiate between these possibilities we have studied survival of serum-deprived PC12-trkB cells stably expressing TK+. PC12-trkB cells were observed to display constitutive trkB kinase activity which leads to survival of a cell subpopulation in the absence of added brain-derived neurotrophic factor (BDNF) and serum. Exogenous BDNF significantly increased cell survival, and this increase was inhibited by BDNF neutralizing antibody. The antibody treatment had no effect on the constitutive TK+ activity. Transfected T1 completely inhibited survival by BDNF or constitutive trkB kinase activity in PC12-trkB cells similarly to tyrosine kinase inhibitor K252a. In addition, T1 coimmunoprecipitated with TK+ and inhibited its autophosphorylation by BDNF. These data suggest that truncated T1 inhibits TK+ signaling by dominant negative action.
Insights
Truncated trkB.T1 (T1) neurotrophin receptor inhibits full-length trkB.TK+ (TK+) signaling. T1 acts as a dominant-negative receptor, blocking both constitutive and BDNF-induced signaling pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Signaling
Background:
- The neurotrophin receptor trkB.TK+ (TK+) plays a crucial role in neuronal survival and function.
- Truncated trkB.T1 (T1) is known to inhibit TK+ signaling, but the mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which truncated trkB.T1 (T1) inhibits full-length trkB.TK+ (TK+) signaling.
- To differentiate between ligand trapping and dominant-negative receptor activity of T1.
Main Methods:
- Studied survival of serum-deprived PC12-trkB cells stably expressing TK+.
- Utilized BDNF stimulation, BDNF neutralizing antibody, and T1 transfection.
- Performed co-immunoprecipitation to assess receptor interactions and autophosphorylation.
Main Results:
- PC12-trkB cells exhibited constitutive TK+ activity and survival, independent of exogenous BDNF.
- T1 transfection completely inhibited survival induced by BDNF or constitutive TK+ activity.
- T1 co-immunoprecipitated with TK+ and inhibited its autophosphorylation, similar to tyrosine kinase inhibitor K252a.
Conclusions:
- Truncated trkB.T1 (T1) inhibits full-length trkB.TK+ (TK+) signaling.
- T1 functions as a dominant-negative receptor, interfering with TK+ autophosphorylation and downstream signaling.
- The findings support a dominant-negative mechanism rather than ligand trapping for T1's inhibitory action.
Related Concept Videos
Enzyme-linked Receptors
TGF - β Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
